These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 30542708)

  • 1. Combination of serum microRNAs and ultrasound profile as predictive biomarkers of diagnosis and prognosis for papillary thyroid microcarcinoma.
    Zhang Y; Pan J; Xu D; Yang Z; Sun J; Sun L; Wu Y; Qiao H
    Oncol Rep; 2018 Dec; 40(6):3611-3624. PubMed ID: 30542708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative ultrasonography and serum thyroid-stimulating hormone on predicting central lymph node metastasis in thyroid nodules as or suspicious for papillary thyroid microcarcinoma.
    Gao Y; Qu N; Zhang L; Chen JY; Ji QH
    Tumour Biol; 2016 Jun; 37(6):7453-9. PubMed ID: 26678888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma.
    Yu S; Liu Y; Wang J; Guo Z; Zhang Q; Yu F; Zhang Y; Huang K; Li Y; Song E; Zheng XL; Xiao H
    J Clin Endocrinol Metab; 2012 Jun; 97(6):2084-92. PubMed ID: 22472564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
    Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
    PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of ultrasonographic features for lymph node metastasis in papillary thyroid microcarcinoma: a single-center retrospective study.
    Liu Z; Zeng W; Liu C; Wang S; Xiong Y; Guo Y; Li X; Sun S; Chen T; Maimaiti Y; Yu P; Huang T
    World J Surg Oncol; 2017 Jan; 15(1):32. PubMed ID: 28125992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between preoperative thyrotrophin and clinicopathological and aggressive features of papillary thyroid cancer.
    Tam AA; Ozdemir D; Aydın C; Bestepe N; Ulusoy S; Sungu N; Ersoy R; Cakir B
    Endocrine; 2018 Mar; 59(3):565-572. PubMed ID: 29374347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
    Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
    J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic monitoring of circulating microRNAs as a predictive biomarker for the diagnosis and recurrence of papillary thyroid carcinoma.
    Zhang Y; Xu D; Pan J; Yang Z; Chen M; Han J; Zhang S; Sun L; Qiao H
    Oncol Lett; 2017 Jun; 13(6):4252-4266. PubMed ID: 28599426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of ki67 in papillary thyroid microcarcinoma and its clinical significance.
    Zhou Y; Jiang HG; Lu N; Lu BH; Chen ZH
    Asian Pac J Cancer Prev; 2015; 16(4):1605-8. PubMed ID: 25743839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative prediction of papillary thyroid microcarcinoma via multiparameter ultrasound.
    Ma HJ; Yang JC; Leng ZP; Chang Y; Kang H; Teng LH
    Acta Radiol; 2017 Nov; 58(11):1303-1311. PubMed ID: 28194993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive diagnosis of papillary thyroid microcarcinoma: a NMR-based metabolomics approach.
    Lu J; Hu S; Miccoli P; Zeng Q; Liu S; Ran L; Hu C
    Oncotarget; 2016 Dec; 7(49):81768-81777. PubMed ID: 27835583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum microRNA profiling to distinguish papillary thyroid cancer from benign thyroid masses.
    Graham ME; Hart RD; Douglas S; Makki FM; Pinto D; Butler AL; Bullock M; Rigby MH; Trites JR; Taylor SM; Singh R
    J Otolaryngol Head Neck Surg; 2015 Sep; 44(1):33. PubMed ID: 26341226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered Serum MicroRNA Profile May Serve as an Auxiliary Tool for Discriminating Aggressive Thyroid Carcinoma from Nonaggressive Thyroid Cancer and Benign Thyroid Nodules.
    Zhang A; Wang C; Lu H; Chen X; Ba Y; Zhang C; Zhang CY
    Dis Markers; 2019; 2019():3717683. PubMed ID: 31636734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma.
    Kunavisarut T; Kak I; Macmillan C; Ralhan R; Walfish PG
    BMC Cancer; 2012 Nov; 12():523. PubMed ID: 23153310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up ultrasonography after lobectomy in papillary thyroid microcarcinoma patients: A single-center study.
    Kim DW
    Endocr Res; 2016 Aug; 41(3):213-7. PubMed ID: 26864682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasonography is valuable in evaluation of papillary thyroid microcarcinoma based on 5 mm tumor size.
    Xia S; Dong Y; Kang H; Zhan W
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S319-S323. PubMed ID: 29970683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ANALYSIS OF POSTOPERATIVE ULTRASONOGRAPHY SURVEILLANCE AFTER HEMITHYROIDECTOMY IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA: A MULTICENTER STUDY.
    Baek HJ; Kim DW; Lee CY; Huh JY; Sung JY; Choi YJ
    Endocr Pract; 2017 Jul; 23(7):794-802. PubMed ID: 28448763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary thyroid microcarcinoma might progress during pregnancy.
    Shindo H; Amino N; Ito Y; Kihara M; Kobayashi K; Miya A; Hirokawa M; Miyauchi A
    Thyroid; 2014 May; 24(5):840-4. PubMed ID: 24397849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma.
    Karatzas T; Vasileiadis I; Kapetanakis S; Karakostas E; Chrousos G; Kouraklis G
    Am J Surg; 2013 Oct; 206(4):586-93. PubMed ID: 23790258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal miRNAs are potential diagnostic biomarkers between malignant and benign thyroid nodules based on next-generation sequencing.
    Pan Q; Zhao J; Li M; Liu X; Xu Y; Li W; Wu S; Su Z
    Carcinogenesis; 2020 Mar; 41(1):18-24. PubMed ID: 31560760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.